PGx for Benefit Providers and Plans

Prescription drug spending in the U.S. is topping $360 billion per year. We already know failure rates for some classes of medications can be as high as 50–75%. If healthcare is your business, you can’t afford to be guessing anymore.

Pharmacogenomics (PGx) can provide healthcare providers unparalleled insight into how to prescribe the best medications at the right dosages, based on their unique genetics, and save you money in the process.

Most medications on the market today were developed with population-level testing methods, but the result is often ineffective therapies and adverse drug reactions that generate more than 280,000 hospital admissions annually in the U.S.

As a benefit provider, plan administrator, managed care organization or pharmacy benefit manager, integrating PGx into your current offering could become the single most valuable tool you have to control costs and improve care for your membership.

RxGenomix can partner with you to turn claims data or health records into critical insights such as:

  • Population-level financials
  • Estimated return on investment
  • Potential genetic risks
  • Drug interaction risks
  • Age-related toxicity issues
  • Anticholinergic burden
  • Presence of FDA black box warnings
  • Lifestyle risks
  • Pregnancy/lactation risks

Contact RxGenomix to learn more about how to improve care while maximizing the efficiency of your medication spending.